Feiyu Lu

机构：First Affiliated Hospital of Guangzhou Medical University, Nanjing Medical University, Guangzhou Medical University · ORCID：0000-0002-3688-9759

发表论文 26 篇 · 总被引 459 次 · h-index 12

代表论文

Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer (2023 · Cell & Bioscience · 被引 70)
FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression (2023 · International Journal of Biological Sciences · 被引 69)
Hypoxia upregulating ACSS2 enhances lipid metabolism reprogramming through HMGCS1 mediated PI3K/AKT/mTOR pathway to promote the progression of pancreatic neuroendocrine neoplasms (2024 · Journal of Translational Medicine · 被引 49)
ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner (2023 · Journal of Translational Medicine · 被引 42)
FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β‐catenin pathway (2023 · Cancer Science · 被引 40)
WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA ‐mediated by YTHDC1 to promote colorectal cancer development (2023 · The FASEB Journal · 被引 36)